Pricing Log in Create free account

CNS Pharmaceuticals, Inc. (CNSP) vs Curis, Inc. (CRIS)

CNS Pharmaceuticals, Inc. and Curis, Inc. are both Biotechnology companies. CNS Pharmaceuticals, Inc. and Curis, Inc. are of similar size ($5.9M and $5.7M). Across the 9 metrics below, CNS Pharmaceuticals, Inc. leads on 5 and Curis, Inc. on 4.

Valuation

Metric CNSP CRIS Biotechnology median
P/E n/m n/m 10.60
P/S n/m 0.20 9.40
P/B 1.46 0.40 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.29 0.66
EV/Sales n/m (0.27) 9.02
Earnings yield (606.43%) (1,615.91%) (32.88%)
Free cash flow yield (50.55%) (1,649.45%) (23.13%)

Profitability

Metric CNSP CRIS Biotechnology median
Gross margin 0.00% 99.52% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (106.62%) 455.35% (51.96%)
Return on assets (91.64%) (87.76%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CNSP CRIS Biotechnology median
Revenue growth (TTM) — (13.43%) 6.76%
EPS growth (last fiscal year) 92.34% 91.57% 29.88%
Revenue growth, 5-year CAGR — (2.71%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CNSP CRIS Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.86 0.49 4.97
Net debt to EBITDA 0.45 0.91 1.01

Dividend

Metric CNSP CRIS Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CNSP CRIS Biotechnology median
Market cap 5.86m 5.67m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack